NYSE: VRX and TSX: VRX) announced today that it has received approval from the Food and Drug Administration (FDA) for its Supplemental New Drug Application (sNDA) for
Retin-A Micro (tretinoin) Gel microsphere 0.
A national survey conducted on behalf of
Retin-A Micro Pump has found that acne can negatively impact many aspects of an adult's life--professional, academic, physical and social--and a lack of knowledge may be preventing or hindering appropriate treatment options.
The Company recorded a gain on the sale of its interests in royalties from sales of
Retin-A Micro and Carac of $23,421,000 in the first quarter of 2006.
The safety of the Microsponge systems has been well-established and they are used in several over-the-counter drug and skin care products besides the two prescription products,
Retin-A Micro and the new 5-FU product.
In February 1997, Advanced Polymer received FDA approval for the first product covered by this agreement, Microsponge-entrapped tretinoin, now marketed by Ortho Dermatological under the name
Retin-A Micro.
First quarter royalties on sales of Carac and
Retin-A Micro grew by 18% and 7%, respectively.
Ortho Dermatological, a member of the Johnson & Johnson family of companies, is Advanced Polymer's marketing partner and rapidly launched
Retin-A Micro nationwide.
Fourth quarter royalties on sales of
Retin-A Micro and Carac grew by 10% and 18%, respectively.
RETIN-A MICRO is indicated for the topical treatment of acne vulgaris.
Quantum, recently named "Agency of the Year" by DTC Perspectives magazine, received the Silver Award in the "Best Branded Television" and "Best Radio Campaign" categories for its work on consumer campaigns for Crestor, a cholesterol treatment, and
Retin-A Micro, a topical acne treatment, respectively.
FDA marketing clearance of
Retin-A Micro is a significant
Crestor, a cholesterol treatment, received a Bronze Award in the "New Brand of the Year" category, and
Retin-A Micro, a topical acne treatment, was awarded the Bronze in the "Brand of the Year Over $15 Million in Spending" category.
